Perkins Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Perkins Investment Management's ABBV Position: Q1 2017 in Review
Perkins Investment Management reduced its AbbVie (ABBV) stake by 0.14% in Q1 2017, selling an estimated $5.59K and leaving 62,906 shares worth $4.1M. The position accounts for 0.05% of the portfolio, ranked #174.
Perkins Investment Management first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $13.2M in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.
- Perkins Investment Management held 62,906 shares of AbbVie worth $4.1M as of Q1 2017.
- Perkins Investment Management sold 89 AbbVie shares in Q1 2017, an estimated $5.59K.
- AbbVie made up 0.05% of Perkins Investment Management's portfolio in Q1 2017, its #174 holding.
- Perkins Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
- Perkins Investment Management's AbbVie position peaked at $13.2M in Q2 2015.
- 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.
Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.